AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17544379 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) in women
Number of subjects: 83
Study 17544379 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) in men
Number of subjects: 83
Study 17544379 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HTTLPR influence in women during ATD
Number of subjects: 83
Study 15363069 — intervention group
Group type: EXPERIMENTAL
Intervention: EP-guided therapy
Number of subjects: 100
Study 11432797 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial daily dosing of 6 MU Interferon-alpha-2a daily for 12 weeks, then reduced to 6 MU three times weekly until week 12 and 3 MU three times weekly thereafter until month 12.
Number of subjects: 64
Study 11432797 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy with 5 MU Interferon-alpha-2b or 6 MU Interferon-alpha-2a three times a week for 12 months.
Number of subjects: 64
Study 9730559 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir treatment
Number of subjects: 153
Study 9730559 — intervention group
Group type: COMPARATOR
Intervention: Ganciclovir untreated (OKT3 group)
Number of subjects: 153
Study 9730559 — intervention group
Group type: COMPARATOR
Intervention: Ganciclovir untreated (methylprednisolone group)
Number of subjects: 153
Study 9730559 — intervention group
Group type: COMPARATOR
Intervention: Ciclosporin A treated group
Number of subjects: 153
Study 9730559 — intervention group
Group type: COMPARATOR
Intervention: Low-grade CMV infection (no treatment)
Number of subjects: 153
Study 7982253 — intervention group
Group type: EXPERIMENTAL
Intervention: Brodimoprim 200 mg tablets once a day (400 mg on the first day as a loading dose)
Number of subjects: 49
Study 7982253 — intervention group
Group type: COMPARATOR
Intervention: Cephalexin 500 mg tablets three times a day for 8 to 12 days
Number of subjects: 49
Study 7982253 — intervention group
Group type: EXPERIMENTAL
Intervention: Brodimoprim
Number of subjects: 49
Study 7982253 — intervention group
Group type: COMPARATOR
Intervention: Cephalexin
Number of subjects: 49
Study 7982253 — intervention group
Group type: EXPERIMENTAL
Intervention: Brodimoprim and Cephalexin
Number of subjects: 49
Study 2534418 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing left ventricular end-diastolic diameter (LVEDD)
Number of subjects: 18
Study 2534418 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasing left ventricular end-diastolic diameter (LVEDD)
Number of subjects: 18
Study 2534418 — intervention group
Group type: COMPARATOR
Intervention: Cold pressor test
Number of subjects: 18
Study 808445 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical disodium cromoglycate (DSCG) 200 mg by enema twice daily and 100 mg orally three times daily
Number of subjects: 30
Study 808445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31953524 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast
Number of subjects: 526
Study 30642293 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide depot/autogel 120 mg every 4 weeks for 96 weeks
Number of subjects: 0
Study 30642293 — intervention group
Group type: COMPARATOR
Intervention: Placebo every 4 weeks for 96 weeks
Number of subjects: 0
Study 30642293 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide
Number of subjects: 0
Study 27663451 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineural dexamethasone (8 mg)
Number of subjects: 150
Study 27663451 — intervention group
Group type: COMPARATOR
Intervention: Intravenous dexamethasone (8 mg)
Number of subjects: 150
Study 25096818 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (DHA and EPA) - 2 MorDHA capsules per day for 14 months
Number of subjects: 104
Study 25096818 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 104
Study 24199774 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated tea (600 mL of oolong tea treated by three Buddhist monks)
Number of subjects: 189
Study 24199774 — intervention group
Group type: COMPARATOR
Intervention: Untreated tea (600 mL of ordinary oolong tea)
Number of subjects: 189
Study 24199774 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in drinking treated tea
Number of subjects: 189
Study 24199774 — intervention group
Group type: COMPARATOR
Intervention: No belief in drinking treated tea
Number of subjects: 189
Study 21593492 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily presentation of macaroni and cheese meal for 1 week
Number of subjects: 32
Study 21593492 — intervention group
Group type: COMPARATOR
Intervention: Once-weekly presentation of macaroni and cheese meal for 5 weeks
Number of subjects: 32
Study 19500854 — intervention group
Group type: COMPARATOR
Intervention: Spectacles
Number of subjects: 80
Study 19500854 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectacles with Bangerter filters
Number of subjects: 80
Study 19500854 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 17397033 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 years of androgen suppression therapy (AST) plus external beam radiation therapy (RT)
Number of subjects: 311
Study 17397033 — intervention group
Group type: COMPARATOR
Intervention: 6 months of androgen suppression therapy (AST) plus external beam radiation therapy (RT)
Number of subjects: 311
Study 12547878 — intervention group
Group type: EXPERIMENTAL
Intervention: Maggot therapy
Number of subjects: 18
Study 12547878 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 18
Study 10703801 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital (20 mg/kg)
Number of subjects: 340
Study 10703801 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study 10703801 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital (20 mg/kg) plus three or more doses of diazepam
Number of subjects: 340
Study 9352699 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg once daily
Number of subjects: 256
Study 9352699 — intervention group
Group type: COMPARATOR
Intervention: Alfuzosin 2.5 mg three times daily
Number of subjects: 256
Study 8450526 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg once daily)
Number of subjects: 97
Study 8450526 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine retard (20 mg twice daily)
Number of subjects: 97
Study 8450526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 3767015 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 cm wide tourniquet at 300 mm Hg
Number of subjects: 11
Study 3767015 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 cm wide tourniquet at 400 mm Hg
Number of subjects: 11
Study 3767015 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 cm wide tourniquet
Number of subjects: 11
Study 3767015 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 cm wide tourniquet at 260 mm Hg
Number of subjects: 11
Study 3767015 — intervention group
Group type: EXPERIMENTAL
Intervention: Bier blockade tourniquet (5 cm wide)
Number of subjects: 11
Study 30464372 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stabilization exercise (CSE)
Number of subjects: 38
Study 30464372 — intervention group
Group type: COMPARATOR
Intervention: Control group (thermal therapy)
Number of subjects: 38
Study 27495219 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation of the left posterior parietal cortex
Number of subjects: 0
Study 27495219 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation
Number of subjects: 0
Study 27495219 — intervention group
Group type: COMPARATOR
Intervention: Transcranial direct current stimulation of the left primary sensorimotor cortex
Number of subjects: 0
Study 23804546 — intervention group
Group type: EXPERIMENTAL
Intervention: Actiponin (450 mg day(-1))
Number of subjects: 80
Study 23804546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 22739693 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13) coadministered with trivalent inactivated influenza vaccine (TIV)
Number of subjects: 1116
Study 22739693 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1116
Study 22739693 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 1116
Study 22739693 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of PCV13 and TIV
Number of subjects: 1116
Study 20447958 — intervention group
Group type: EXPERIMENTAL
Intervention: Damato campimetry
Number of subjects: 100
Study 20447958 — intervention group
Group type: COMPARATOR
Intervention: Humphrey automated perimetry
Number of subjects: 100
Study 20447958 — intervention group
Group type: EXPERIMENTAL
Intervention: Damato campimetry and Humphrey automated perimetry
Number of subjects: 100
Study 18573802 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX (Methotrexate) + infliximab
Number of subjects: 38
Study 18573802 — intervention group
Group type: COMPARATOR
Intervention: Placebo + infliximab
Number of subjects: 38
Study 16334714 — intervention group
Group type: EXPERIMENTAL
Intervention: Needling at 'Sitian' points
Number of subjects: 68
Study 16334714 — intervention group
Group type: COMPARATOR
Intervention: Needling at cervical Jiaji points
Number of subjects: 68
Study 12657842 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial carbon dioxide rebreathing technique
Number of subjects: 25
Study 12657842 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled mechanical ventilation with low minute ventilation
Number of subjects: 25
Study 12657842 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous breathing
Number of subjects: 25
Study 12657842 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled mechanical ventilation with large tidal volume
Number of subjects: 25
Study 10376904 — intervention group
Group type: EXPERIMENTAL
Intervention: IV administration of metformin (25 mg/kg)
Number of subjects: 6
Study 10376904 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of metformin (25 mg/kg)
Number of subjects: 6
Study 10376904 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer simulations of oral metformin (2 mg/kg every 12 hours)
Number of subjects: 6
Study 8901787 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (15 mg/d) for 3 months
Number of subjects: 0
Study 8901787 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0
Study 1859009 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 5 micrograms.kg‐1
Number of subjects: 80
Study 1859009 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 2.5 micrograms.kg‐1
Number of subjects: 80
Study 1859009 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 1.2 micrograms.kg‐1
Number of subjects: 80
Study 1859009 — intervention group
Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 80
Study 6181653 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg femoxetine daily for 6 weeks
Number of subjects: 42
Study 6181653 — intervention group
Group type: COMPARATOR
Intervention: 150 mg desipramine daily for 6 weeks
Number of subjects: 42
Study 31026713 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced training (10 hours plus ongoing coaching)
Number of subjects: 60
Study 31026713 — intervention group
Group type: COMPARATOR
Intervention: Basic training (2 hours)
Number of subjects: 60
Study 29326015 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous enoxaparin administered in the abdomen
Number of subjects: 301
Study 29326015 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous enoxaparin administered in the arm
Number of subjects: 301
Study 27221026 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon Eustachian tuboplasty (BET) only
Number of subjects: 90
Study 27221026 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon Eustachian tuboplasty (BET) + tympanic paracentesis (TP)
Number of subjects: 90
Study 27221026 — intervention group
Group type: COMPARATOR
Intervention: Tympanic paracentesis (TP) only
Number of subjects: 90
Study 27221026 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon Eustachian tuboplasty (BET) and BET + tympanic paracentesis (TP)
Number of subjects: 90
Study 25082304 — intervention group
Group type: EXPERIMENTAL
Intervention: Benefits counseling (4 sessions)
Number of subjects: 84
Study 25082304 — intervention group
Group type: COMPARATOR
Intervention: Control condition (orientation to the U.S Department of Veterans Affairs health care system and services)
Number of subjects: 84
Study 22741618 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisinin-piperaquine (Artequick®) - 2.8 mg/kg artemisinin plus 17.1 mg/kg piperaquine per day for 2 days
Number of subjects: 128
Study 22741618 — intervention group
Group type: COMPARATOR
Intervention: Artesunate-amodiaquine (Coarsucam™) - 4.7 mg/kg artesunate plus 12.6 mg/kg amodiaquine per day for 3 days
Number of subjects: 128
Study 20219120 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal instructions from the supplier combined with training in the use of CCTVs
Number of subjects: 122
Study 20219120 — intervention group
Group type: COMPARATOR
Intervention: Instructions from the supplier only
Number of subjects: 122
Study 17459695 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 15 mg i.v. bolus 20 min before induction, followed by an infusion of 7.5 mg/h
Number of subjects: 90
Study 17459695 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 90
Study 16089136 — intervention group
Group type: EXPERIMENTAL
Intervention: tongjingning granule (TJN)
Number of subjects: 120
Study 16089136 — intervention group
Group type: COMPARATOR
Intervention: aspirin
Number of subjects: 120
Study 12608518 — intervention group
Group type: EXPERIMENTAL
Intervention: I-Visc Phaco
Number of subjects: 96
Study 12608518 — intervention group
Group type: COMPARATOR
Intervention: Healon5
Number of subjects: 96
Study 10095154 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 100 microgram subcutaneously
Number of subjects: 20
Study 10095154 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 200 microgram subcutaneously
Number of subjects: 20
Study 10095154 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 100 microgram intravenously (bolus)
Number of subjects: 20
Study 10095154 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 25 microgram/h intravenously (continuous infusion)
Number of subjects: 20
Study 10095154 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 100 microgram/h intravenously (continuous infusion)
Number of subjects: 20
Study 10095154 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8690630 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy at 4 months after surgery for pre/perimenopausal patients
Number of subjects: 718
Study 8690630 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy at 7 months after surgery for pre/perimenopausal patients
Number of subjects: 718
Study 8690630 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy at 2 months after surgery for postmenopausal patients
Number of subjects: 718
Study 8690630 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy at 4 months after surgery for postmenopausal patients
Number of subjects: 718
Study 8690630 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy after three or six cycles of CMF for pre/perimenopausal women
Number of subjects: 718
Study 8690630 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy after no cycles or three cycles of CMF for postmenopausal women
Number of subjects: 718
Study 8690630 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy
Number of subjects: 718
Study 1751562 — intervention group
Group type: EXPERIMENTAL
Intervention: Iotrolan-300
Number of subjects: 50
Study 1751562 — intervention group
Group type: COMPARATOR
Intervention: Iopamidol-300
Number of subjects: 50
Study 6814984 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate disodium (EHDP)
Number of subjects: 26
Study 31652220 — intervention group
Group type: EXPERIMENTAL
Intervention: Red LED photomodulation (633 nm) for 20 minutes at 4 weekly sessions (105 mW/cm, 126 J/cm)
Number of subjects: 14
Study 31652220 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 14
Study 31652220 — intervention group
Group type: EXPERIMENTAL
Intervention: Red LED photomodulation (633 nm)
Number of subjects: 14
Study 30946268 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric Training (PT)
Number of subjects: 21
Study 30946268 — intervention group
Group type: COMPARATOR
Intervention: Active Control (CG)
Number of subjects: 21
Study 28784510 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic beverage (150mL daily)
Number of subjects: 29
Study 28784510 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage (150mL daily)
Number of subjects: 29
Study 28784510 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic beverage
Number of subjects: 29
Study 28784510 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 29
Study 25660828 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable pulsed electromagnetic field (PEMF) therapy device
Number of subjects: 120
Study 25660828 — intervention group
Group type: COMPARATOR
Intervention: Placebo (disabled PEMF device)
Number of subjects: 120
Study 25660828 — intervention group
Group type: COMPARATOR
Intervention: No device (control group)
Number of subjects: 120
Study 23954024 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-managed loaded exercise
Number of subjects: 24
Study 23954024 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy treatment
Number of subjects: 24
Study 23954024 — intervention group
Group type: COMPARATOR
Intervention: Comparison of SPADI scores
Number of subjects: 24
Study 22179446 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D HD video system
Number of subjects: 30
Study 22179446 — intervention group
Group type: COMPARATOR
Intervention: 2D HD video system
Number of subjects: 30
Study 19775034 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-sparing postoperative analgesia protocol (tramadol patient‐controlled analgesia, parecoxib and rescue‐only morphine)
Number of subjects: 62
Study 19775034 — intervention group
Group type: COMPARATOR
Intervention: Standard morphine patient‐controlled analgesia
Number of subjects: 62
Study 19775034 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-sparing postoperative analgesia protocol
Number of subjects: 62
Study 17288687 — intervention group
Group type: EXPERIMENTAL
Intervention: EPs 7630 solution (30 drops three times daily for 7 days)
Number of subjects: 217
Study 17288687 — intervention group
Group type: COMPARATOR
Intervention: Placebo (30 drops three times daily for 7 days)
Number of subjects: 217
Study 17288687 — intervention group
Group type: EXPERIMENTAL
Intervention: EPs 7630 solution
Number of subjects: 217
Study 11092154 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-hour information and motivation session plus mailed personal feedback on drinking
Number of subjects: 37
Study 11092154 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed feedback only
Number of subjects: 37
Study 11092154 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 37
Study 8819128 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional GM-CSF (15-50 mg doses)
Number of subjects: 13
Study 8819128 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional GM-CSF
Number of subjects: 13
Study 1453404 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraovular intrauterine contraction monitoring
Number of subjects: 64
Study 1453404 — intervention group
Group type: COMPARATOR
Intervention: Intraovular intrauterine contraction monitoring
Number of subjects: 64
Study 3881947 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam
Number of subjects: 40
Study 3881947 — intervention group
Group type: COMPARATOR
Intervention: Tobramycin
Number of subjects: 40
Study 31599729 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart mobile health (mHealth) tool
Number of subjects: 87
Study 31599729 — intervention group
Group type: COMPARATOR
Intervention: Paper action plan
Number of subjects: 87
Study 29716553 — intervention group
Group type: EXPERIMENTAL
Intervention: Preschool-based capacity building intervention
Number of subjects: 34
Study 29716553 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 34
Study 30230765 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitazoxanide (NTZ)
Number of subjects: 120
Study 30230765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 24589725 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-Care-Program (counseling lessons for 6 months on nutrition, hygiene, coping with stigma and discrimination)
Number of subjects: 201
Study 24589725 — intervention group
Group type: COMPARATOR
Intervention: Usual-Care (control group)
Number of subjects: 201
Study 24589725 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-Care-Program
Number of subjects: 201
Study 22643234 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual (AV) stimuli presented peripherally to young participants
Number of subjects: 0
Study 22643234 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual (AV) stimuli presented peripherally to elderly participants
Number of subjects: 0
Study 20041960 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal hemodialysis (NHD) 5 to 6 nights per week for 6 to 10 hours per night
Number of subjects: 0
Study 20041960 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemodialysis (CvHD) thrice weekly for 6 months
Number of subjects: 0
Study 20041960 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal hemodialysis (NHD)
Number of subjects: 0
Study 16899377 — intervention group
Group type: EXPERIMENTAL
Intervention: Words presented in the colour they were most often presented in (75% of the time)
Number of subjects: 0
Study 16899377 — intervention group
Group type: EXPERIMENTAL
Intervention: Words presented in the colour they were most often presented in (50% of the time)
Number of subjects: 0
Study 16899377 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency-unaware participants
Number of subjects: 0
Study 16899377 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency effect
Number of subjects: 0
Study 16899377 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural control
Number of subjects: 0